Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 17496896)

1.

Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication.

Hodges A, Sharrocks K, Edelmann M, Baban D, Moris A, Schwartz O, Drakesmith H, Davies K, Kessler B, McMichael A, Simmons A.

Nat Immunol. 2007 Jun;8(6):569-77. Epub 2007 May 13.

PMID:
17496896
2.

Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts.

Mummidi S, Catano G, Lam L, Hoefle A, Telles V, Begum K, Jimenez F, Ahuja SS, Ahuja SK.

J Biol Chem. 2001 Aug 31;276(35):33196-212. Epub 2001 May 3.

3.

DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation.

Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O.

Blood. 2004 Apr 1;103(7):2648-54. Epub 2003 Oct 23.

4.

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.

Granelli-Piperno A, Pritsker A, Pack M, Shimeliovich I, Arrighi JF, Park CG, Trumpfheller C, Piguet V, Moran TM, Steinman RM.

J Immunol. 2005 Oct 1;175(7):4265-73.

5.
6.

Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.

Dakappagari N, Maruyama T, Renshaw M, Tacken P, Figdor C, Torensma R, Wild MA, Wu D, Bowdish K, Kretz-Rommel A.

J Immunol. 2006 Jan 1;176(1):426-40.

7.

Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.

Garcia-Vallejo JJ, Koning N, Ambrosini M, Kalay H, Vuist I, Sarrami-Forooshani R, Geijtenbeek TB, van Kooyk Y.

Int Immunol. 2013 Apr;25(4):221-33. doi: 10.1093/intimm/dxs115. Epub 2013 Jan 4.

8.

Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes.

Engering A, Van Vliet SJ, Geijtenbeek TB, Van Kooyk Y.

Blood. 2002 Sep 1;100(5):1780-6.

9.

Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.

Requena M, Bouhlal H, Nasreddine N, Saidi H, Gody JC, Aubry S, Grésenguet G, Kazatchkine MD, Sekaly RP, Bélec L, Hocini H.

Immunology. 2008 Apr;123(4):508-18. Epub 2007 Nov 10.

10.

Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.

Burleigh L, Lozach PY, Schiffer C, Staropoli I, Pezo V, Porrot F, Canque B, Virelizier JL, Arenzana-Seisdedos F, Amara A.

J Virol. 2006 Mar;80(6):2949-57.

11.

HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells.

Gringhuis SI, van der Vlist M, van den Berg LM, den Dunnen J, Litjens M, Geijtenbeek TB.

Nat Immunol. 2010 May;11(5):419-26. doi: 10.1038/ni.1858. Epub 2010 Apr 4.

PMID:
20364151
12.

DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells.

Arrighi JF, Pion M, Garcia E, Escola JM, van Kooyk Y, Geijtenbeek TB, Piguet V.

J Exp Med. 2004 Nov 15;200(10):1279-88.

13.

A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance.

van Kooyk Y, Appelmelk B, Geijtenbeek TB.

Trends Mol Med. 2003 Apr;9(4):153-9. Review.

PMID:
12727141
14.

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

Tacken PJ, de Vries IJ, Gijzen K, Joosten B, Wu D, Rother RP, Faas SJ, Punt CJ, Torensma R, Adema GJ, Figdor CG.

Blood. 2005 Aug 15;106(4):1278-85. Epub 2005 May 5.

15.

DNA and protein co-administration induces tolerogenic dendritic cells through DC-SIGN mediated negative signals.

Li J, Geng S, Liu X, Liu H, Jin H, Liu CG, Wang B.

Hum Vaccin Immunother. 2013 Oct;9(10):2237-45. doi: 10.4161/hv.25011. Epub 2013 Jun 4.

16.

DCIR interacts with ligands from both endogenous and pathogenic origin.

Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.

Immunol Lett. 2014 Mar-Apr;158(1-2):33-41. doi: 10.1016/j.imlet.2013.11.007. Epub 2013 Nov 14.

PMID:
24239607
17.

The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.

van Die I, van Vliet SJ, Nyame AK, Cummings RD, Bank CM, Appelmelk B, Geijtenbeek TB, van Kooyk Y.

Glycobiology. 2003 Jun;13(6):471-8. Epub 2003 Feb 20.

18.

CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.

Wang JH, Janas AM, Olson WJ, KewalRamani VN, Wu L.

J Virol. 2007 Mar;81(5):2497-507. Epub 2006 Dec 6.

19.

Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.

van Kooyk Y, Unger WW, Fehres CM, Kalay H, García-Vallejo JJ.

Mol Immunol. 2013 Sep;55(2):143-5. doi: 10.1016/j.molimm.2012.10.031. Epub 2012 Nov 14. Review.

PMID:
23158834
20.

DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.

Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K, Wigdahl B.

J Virol. 2009 Nov;83(21):10908-21. doi: 10.1128/JVI.01054-09. Epub 2009 Aug 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk